These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 22522056)
1. Evaluation of factors influencing accuracy in the analysis of succinylacetone in dried blood spots. Peng M; Liu L; Peng L Clin Chim Acta; 2012 Aug; 413(15-16):1265-9. PubMed ID: 22522056 [TBL] [Abstract][Full Text] [Related]
2. Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS. Al-Dirbashi OY; Rashed MS; Jacob M; Al-Ahaideb LY; Al-Amoudi M; Rahbeeni Z; Al-Sayed MM; Al-Hassnan Z; Al-Owain M; Al-Zeidan H Biomed Chromatogr; 2008 Nov; 22(11):1181-5. PubMed ID: 18651606 [TBL] [Abstract][Full Text] [Related]
3. [Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1]. Han LS; Ye J; Qiu WJ; Zhang HW; Wang Y; Ji WJ; Gao XL; Li XY; Jin J; Gu XF Zhonghua Er Ke Za Zhi; 2012 Feb; 50(2):126-30. PubMed ID: 22455637 [TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Magera MJ; Gunawardena ND; Hahn SH; Tortorelli S; Mitchell GA; Goodman SI; Rinaldo P; Matern D Mol Genet Metab; 2006 May; 88(1):16-21. PubMed ID: 16448836 [TBL] [Abstract][Full Text] [Related]
5. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055 [TBL] [Abstract][Full Text] [Related]
6. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. la Marca G; Malvagia S; Pasquini E; Innocenti M; Fernandez MR; Donati MA; Zammarchi E Rapid Commun Mass Spectrom; 2008; 22(6):812-8. PubMed ID: 18278819 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel, commercially available mass spectrometry kit for newborn screening including succinylacetone without hydrazine. Metz TF; Mechtler TP; Merk M; Gottschalk A; Lukačin R; Herkner KR; Kasper DC Clin Chim Acta; 2012 Aug; 413(15-16):1259-64. PubMed ID: 22521492 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots. Li Q; Cao D; Huang Y; Xu H; Yu C; Li Z Biomed Chromatogr; 2013 Mar; 27(3):327-34. PubMed ID: 22893355 [TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots. Rao RN; Raju SS; Vali RM; Sankar GG J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():47-54. PubMed ID: 22770781 [TBL] [Abstract][Full Text] [Related]
10. Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program. Zytkovicz TH; Sahai I; Rush A; Odewale A; Johnson D; Fitzgerald E; Britton D; Eaton RB Clin Biochem; 2013 May; 46(7-8):681-4. PubMed ID: 23462696 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence. Lawson G; Cocks E; Tanna S J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 897():72-9. PubMed ID: 22552005 [TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS bioanalysis of loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study. Li W; Doherty J; Moench P; Flarakos J; Tse FL J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 983-984():117-24. PubMed ID: 25645810 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. Allard P; Grenier A; Korson MS; Zytkovicz TH Clin Biochem; 2004 Nov; 37(11):1010-5. PubMed ID: 15498530 [TBL] [Abstract][Full Text] [Related]
14. Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice. Wong P; Pham R; Whitely C; Soto M; Salyers K; James C; Bruenner BA J Pharm Biomed Anal; 2011 Nov; 56(3):604-8. PubMed ID: 21784595 [TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I. la Marca G; Malvagia S; Materazzi S; Della Bona ML; Boenzi S; Martinelli D; Dionisi-Vici C Anal Chem; 2012 Jan; 84(2):1184-8. PubMed ID: 22148291 [TBL] [Abstract][Full Text] [Related]
16. On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. Saussereau E; Lacroix C; Gaulier JM; Goulle JP J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():1-7. PubMed ID: 22281234 [TBL] [Abstract][Full Text] [Related]
17. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. Al-Dirbashi OY; Rashed MS; Brink HJ; Jakobs C; Filimban N; Al-Ahaidib LY; Jacob M; Al-Sayed MM; Al-Hassnan Z; Faqeih E J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):274-80. PubMed ID: 16384749 [TBL] [Abstract][Full Text] [Related]
18. Perforated dried blood spots: a novel format for accurate microsampling. Li F; Zulkoski J; Fast D; Michael S Bioanalysis; 2011 Oct; 3(20):2321-33. PubMed ID: 22011180 [TBL] [Abstract][Full Text] [Related]
19. Distribution of 25-hydroxyvitamin D3 in dried blood spots and implications for its quantitation by tandem mass spectrometry. Kvaskoff D; Ko P; Simila HA; Eyles DW J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():47-52. PubMed ID: 22727750 [TBL] [Abstract][Full Text] [Related]
20. The successful inclusion of succinylacetone as a marker of tyrosinemia type I in Tuscany newborn screening program. la Marca G; Malvagia S; Funghini S; Pasquini E; Moneti G; Guerrini R; Zammarchi E Rapid Commun Mass Spectrom; 2009 Dec; 23(23):3891-3. PubMed ID: 19902423 [No Abstract] [Full Text] [Related] [Next] [New Search]